Views & Analysis | Perspectives on pharma industry issues

Digital

Abstract AI concept, turquoise hexagonals on dark background

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

R&D

A certificate of analysis should be evidence, not a sales do...

Regulators weighing peptide bulk substances can ask whether today's documentation rules fit the risks of this supply chain.

R&D

From phase 1 to phase 3: Scaling radiopharmaceutical trials

Success in radiopharmaceutical development depends on creating and maintaining an integrated, scalable system.

Patients

pharmaphorum podcast Episode 285, Donna Cryer, CryerHealth, LLC

Patients not just at the table, but creating their own: In c...

Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.

R&D

Gravity is an experimental variable pharma has rarely been a...

Microgravity should not be a destination for pharmaceutical R&D, but another experimental environment.

Articles

mHealth Monthly Mashup: Release 6.0 - The gamification of h...

Checking in to his last instalment of the series for 2011, Michael Spitz discusses how gamification has impacted on mobile health. The rapid evolution of smartphones, app stores, and healthcare user behaviours has created an mHealth revolution, one so exponential in...

Articles

Improving diabetes outcomes, one patient at a time

Andi Weiss discusses the barriers to successful diabetes management and what can be done to overcome them. The WHO reports that 346 million people have diabetes worldwide. Underscoring the growing problem, experts anticipate that number...

Articles

Patient perspectives: Lisa Emrich

Continuing our conversations with highly visible epatients, pharmaphorum spoke to Lisa Emrich about her experience of rheumatoid arthritis, multiple sclerosis and pharma. The work that epatient Lisa Emrich does in blogging about her experience helps not one, but two separate groups of individuals as she has been diagnosed with…

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.